Status:
UNKNOWN
Colonisation Efficacy of Oral Probiotic Fast Melt Powder
Lead Sponsor:
BLIS Technologies Limited
Conditions:
Microbial Colonization
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
To evaluate the colonisation efficacy (i.e. ability of the probiotic bacteria to remain in your mouth) of a fast melt powder that quickly dissolves in the mouth. The fast melt powder will contain a St...
Detailed Description
This is a double-blind, randomized controlled study with no cross over to evaluate the colonization efficacy of fast melt powders containing a commercially available probiotic bacterium Streptococcus ...
Eligibility Criteria
Inclusion
- In general good health 18 - 80 years of age.
- Practice good oral hygiene.
Exclusion
- Have a history of autoimmune disease or are immunocompromised.
- Are on concurrent antibiotic therapy or regular antibiotic use within last 1 week
- History of allergy (e.g. dairy).
Key Trial Info
Start Date :
May 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05367518
Start Date
May 15 2022
End Date
June 30 2022
Last Update
May 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Blis Technologies Ltd
Dunedin, Otago, New Zealand, 9012